Plain-English translation of NCT06075199 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is following 1,000 patients who have been found to have intestinal metaplasia—a change in the stomach lining that can sometimes lead to cancer. Researchers will collect small tissue samples from your stomach during a routine endoscopy and monitor you over time to see who develops gastric cancer. By comparing the tissue samples from patients who do and don't develop cancer, the researchers hope to discover biological markers (signs in your tissue) that could predict cancer risk.
Intestinal metaplasia is a known risk factor for gastric cancer, but doctors currently cannot reliably predict which patients with this condition will actually develop cancer. This study aims to find biological markers in stomach tissue that could help doctors identify high-risk patients earlier, potentially allowing for better prevention or early treatment.
You likely qualify if…
You likely don't qualify if…
You will have an initial endoscopy (a camera procedure down your throat) where small tissue samples will be collected from your stomach according to a standard protocol. These samples will be stored for future analysis. After that, you will have regular follow-up endoscopy screenings as part of routine care to monitor for any development of gastric cancer. The study will continue to track you over time, comparing your tissue samples with those of other participants to identify patterns that predict cancer risk.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
South Korea
Sponsor
Seoul National University Hospital
Enrollment target
~1,000 participants
Started
September 2023
Primary completion
June 2033
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Soo-Jeong Cho, MD, PhD
Seoul National University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.